Boats ships
Biotech

Seaport CEO's 'rationale behind going public' via $255M IPO

"We want to develop those programs as far as we can ourselves,” Seaport CEO Daphne Zohar told Fierce.
James Waldron May 1, 2026 12:30pm
AZ

FDA panel rejects AstraZeneca's novel oral SERD proposal

Apr 30, 2026 1:48pm
viking longship warrior boat launch

Ligand tries to disembark from Viking pact, alleging breach

May 1, 2026 8:31am
Golfer devastated after just barely missing a putt

Amgen abandons cancer, Sjögren’s drugs over weak ph.2 data

May 1, 2026 1:45am
New road

J&J axes $5B CAR-T dream months after touting efficacy edge

May 1, 2026 8:26am
Stock market drop
Favicon Fierce Pharma

Summit shares tumble on interim PD-1/VEGF trial miss

May 1, 2026 10:56am
More News

CBER chief Prasad steps aside, deputy takes the reins

May 1, 2026 9:58am

Astellas appoints new top strategist—Chutes & Ladders

May 1, 2026 8:30am

Fierce Biotech Layoff Tracker 2026: Autolus, Replimune & more

Apr 30, 2026 12:30pm

BMS calls time on Zymeworks collab, ending work on bispecific

Apr 30, 2026 10:22am